These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 1716380

  • 1. Nonradical excited oxygen species induce selective thrombolysis in vivo.
    Stief TW.
    Thromb Res; 1991 May 01; 62(3):147-63. PubMed ID: 1716380
    [Abstract] [Full Text] [Related]

  • 2. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW, Stief MH, Ehrenthal W, Darius H, Martin E.
    Thromb Res; 1991 Dec 01; 64(5):597-610. PubMed ID: 1808764
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 4. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 30; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 5. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE, Santoro SA, Sobel BE, Jaffe AS.
    Am J Med; 1984 May 30; 76(5):879-86. PubMed ID: 6232847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The fibrinolytic system in man.
    Collen D, Lijnen HR.
    Crit Rev Oncol Hematol; 1986 May 30; 4(3):249-301. PubMed ID: 2420482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.
    Söhngen W, Mickelson JK, Simpson PJ, Lucchesi BR.
    Thromb Res; 1988 Jul 01; 51(1):63-74. PubMed ID: 3137691
    [Abstract] [Full Text] [Related]

  • 14. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Jul 01; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 15. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW.
    Blood Coagul Fibrinolysis; 1993 Feb 01; 4(1):123-5. PubMed ID: 8457639
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Feb 01; (3):51-4. PubMed ID: 6342687
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.